Literature DB >> 15845454

Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Neil C Rogers1, Emma C Slack, Alexander D Edwards, Martijn A Nolte, Oliver Schulz, Edina Schweighoffer, David L Williams, Siamon Gordon, Victor L Tybulewicz, Gordon D Brown, Caetano Reis e Sousa.   

Abstract

Pattern-recognition receptors (PRRs) detect molecular signatures of microbes and initiate immune responses to infection. Prototypical PRRs such as Toll-like receptors (TLRs) signal via a conserved pathway to induce innate response genes. In contrast, the signaling pathways engaged by other classes of putative PRRs remain ill defined. Here, we demonstrate that the beta-glucan receptor Dectin-1, a yeast binding C type lectin known to synergize with TLR2 to induce TNF alpha and IL-12, can also promote synthesis of IL-2 and IL-10 through phosphorylation of the membrane proximal tyrosine in the cytoplasmic domain and recruitment of Syk kinase. syk-/- dendritic cells (DCs) do not make IL-10 or IL-2 upon yeast stimulation but produce IL-12, indicating that the Dectin-1/Syk and Dectin-1/TLR2 pathways can operate independently. These results identify a novel signaling pathway involved in pattern recognition by C type lectins and suggest a potential role for Syk kinase in regulation of innate immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845454     DOI: 10.1016/j.immuni.2005.03.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  326 in total

1.  CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans.

Authors:  Liangkuan Bi; Sara Gojestani; Weihui Wu; Yen-Michael S Hsu; Jiayuan Zhu; Kiyoshi Ariizumi; Xin Lin
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 3.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

Review 4.  C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.

Authors:  Lara M Kingeter; Xin Lin
Journal:  Cell Mol Immunol       Date:  2012-01-16       Impact factor: 11.530

Review 5.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 6.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 7.  ITAM receptor signaling and the NLRP3 inflammasome in antifungal immunity.

Authors:  Hendrik Poeck; Jürgen Ruland
Journal:  J Clin Immunol       Date:  2010-04-18       Impact factor: 8.317

Review 8.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

9.  STIM1 and STIM2 cooperatively regulate mouse neutrophil store-operated calcium entry and cytokine production.

Authors:  Regina A Clemens; Joshua Chong; Derayvia Grimes; Yongmei Hu; Clifford A Lowell
Journal:  Blood       Date:  2017-07-19       Impact factor: 22.113

10.  Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.

Authors:  Bing Li; Daniel Cramer; Stephanie Wagner; Richard Hansen; Chelsea King; Shelly Kakar; Chuanlin Ding; Jun Yan
Journal:  Clin Immunol       Date:  2007-06-14       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.